Lexaria Bioscience gets AUD 3.67 million R&D tax credit
Lexaria Bioscience received an AUD 3,666,611.98 Australian R&D tax credit, or USD 2.6 million, tied to its GLP-1 clinical study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.